Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with RICE Chemotherapy for Lymphoid Malignancies
NCT00601718Phase 2Completed
- Sponsor
- University of Washington
- Start
- Dec 2007
- Primary completion
- Jun 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in lymphoma, Mantle cell lymphoma (MCL), B-cell lymphoma (BCL), Hodgkin lymphoma (HL), Waldenström macroglobulinemia (WM), sponsored by University of Washington. Started Dec 2007; status: completed.
02
Drugs
vorinostat
03
Conditions
lymphomaMantle cell lymphoma (MCL)B-cell lymphoma (BCL)Hodgkin lymphoma (HL)Waldenström macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00601718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601718.